Latest AI and machine learning research in cardiovascular for healthcare professionals.
The tumor–stroma ratio (TSR) is an established prognostic biomarker across several cancer types, yet its manual assessment remains labour-intensive and subject to inter-observer variability. An artificial intelligence (AI)-based estimate could offer an efficient, consistent alternative for this task. In this study, quantitative comparisons were made between expert humans and an AI model for TSR es...
Deep learning models applied to digital histology can predict gene expression signatures (GES) and offer a low-cost, rapidly available alternative to molecular testing at the time of diagnosis. We optimized transformer-based models to infer GES results and applied this approach to pre-treatment H&E-stained biopsies from 1,940 breast cancer patients treated with neoadjuvant chemotherapy in clinical...
A hallmark of glioblastoma (GBM) is disease recurrence, which occurs in all patients despite tumor resection, radiation, and chemotherapy. A critical ...
The health consequences of ionizing radiation have long been studied, yet significant uncertainties remain, particularly at low doses. In particular, ...
This study evaluated the prognostic performance of RlapsRisk BC, a multimodal deep learning tool designed to predict distant recurrence-free interval ...
The ability of pre-trained large language models (LLMs) to rapidly master novel natural language processing tasks holds transformative potential. Howe...
Thymic involution, characterized by adipose replacement of functional thymic tissue, is a broadly recognized feature of age-related immunosenescence. ...
Breast cancer, which is among the top causes of cancer-related deaths in women worldwide, demonstrates the importance of effective and rapid diagnosti...
Radiotherapy treatment planning is a resource-intensive process characterized by multiple manual steps and clinical hand-offs that contribute to treat...
To prospectively evaluate the feasibility and performance of expedited screening mammogram interpretation for women identified as high-risk by a deep ...
Up to 80% of women breast cancer survivors (BCS), particularly those treated with chemotherapy, report persistent cognitive impairment. Several meta-a...
Immune infiltration is prognostic in triple-negative breast cancer (TNBC), but its role in ER⁺/HER2⁻ disease remains unclear, and conventional scoring...
Homologous recombination deficiency (HRD) confers sensitivity to poly (ADP-ribose) polymerase (PARP) inhibitors and platinum-based chemotherapy, repre...
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer. However, the disconnect between efficacy in randomized tria...
Early-onset colorectal cancer (EOCRC) continues to rise, with the steepest increases observed among Hispanic/Latino (H/L) populations, underscoring th...
The incidence of early-onset colorectal cancer (EOCRC; <50 years) is rising rapidly among populations. Although alterations in the RTK-RAS signaling p...
The increasing availability of electronic health records (EHRs) provides opportunities to apply machine learning (ML) methods in support of clinical d...
Colon Cancer (CC) is among the most frequently diagnosed malignancies and a leading cause of cancer-related death worldwide. Five-year survival varies...
Colorectal cancer (CRC) exhibits marked heterogeneity across age, ancestry, and treatment context, underscored by the rising incidence of early-onset ...
Proteome-guided liquid biopsy tests hold immense promise for the future of early cancer detection. Our previous published work has shown strong perfor...